‘These children could be followed and treated more quickly if they end up getting asthma,’ he said. As the study found a connection between gut bacteria and asthma risk in children, it did not prove effect and cause. Whether giving children probiotics – – good bacteria – – may reduce asthma risk isn’t known, the experts said. Turvey stated the probiotics available in over-the-counter forms usually do not include the four bacterias identified in this study. ‘Studies like ours are identifying particular bacteria combinations that appear to be missing in the kids at the highest threat of asthma,’ he stated. ‘The long-term goal is to observe if we could offer these bacteria back, not the overall nonspecific probiotics.’ Finlay said these findings need to be replicated in larger groupings and in different populations.Beneath the conditions of the financing, Aeolus received $1.0 million in gross proceeds in exchange for 2,500,000 Units , with each Unit made up of one share of Aeolus Pharmaceuticals common stock, and a seven-year warrant to purchase up to 0.75 extra shares of Aeolus Pharmaceuticals common stock at a short exercise price of $0.50 per share, for a per Unit purchase price of $0.40. The proceeds from the transaction will be utilized to fund the manufacture of AEOL 10150, studies of the efficacy of AEOL 10150 in cancer individuals and the pre-clinical development of other Aeolus substances, as well as for general corporate reasons.